Abstract

Several newer atypical antipsychotic drugs appear to be associated with increased risk for development of diabetes. In this partially industry-sponsored analysis of the U.S. Veterans Affairs database, researchers identified nearly 57,000 nondiabetic schizophrenic …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call